| http://www.w3.org/ns/prov#value | - Crucially, the findings of this study also show that the serotypes currently included in existing pneumococcal conjugate formulations account for 49%???74% of deaths in Africa and Asia where the morbidity and mortality of pneumococcal disease are the highest and where most children do not have access to current pneumococcal conjugate vaccines.
|
